Rufinamide
What is Rufinamide Rufinamide is a triazole derivative that is unrelated to currently marketed anticonvulsants. Although rufinamide is only FDA-approved for use in Lennox-Gastaut syndrome, clinical trial data indicate the drug may also be beneficial as adjunctive treatment of refractory partial seizures. Rufinamide was FDA-approved in November 2008 with an orphan drug designation for the …